The application of aptamers especially in the use of drug delivery systems (DDSs) has the potential to develop in vivo nanoparticles for theranosis (therapy+diagnosis). With the advent of medical imaging and radiotherapeutics, this area of research developing the next era of radiopharmaceuticals is both attractive and promising. Overall, nano-radiopharmaceuticals have the potential to solve several problems regarding the in vivo stability of aptamers. This paper discusses a study in the development and proof-of-concept of nano-aptamers and supporting its use as a nano-radiopharmaceutical for the treatment of breast cancer and other potentially related disease states.
info:eu-repo/grantAgreement/Ministry of Education, Youth and Sports/LK/LK21310/CZ/Study of transmutation of Ra-226 and separation of the irradiation products/